(Reuters) – China-based staff of GlaxoSmithKline Plc allegedly handed doctors with cash and other rewards for prescribing Botox, according to the Wall Street Journal, in the latest scandal to hit the British drugmaker which is under investigation by Chinese police for economic crimes.
Internal documents and email showed GSK’s China sales staff were also apparently instructed to use their personal email addresses to discuss marketing strategies related to Botox, the report added.
Read Full Article HERE
Reuters Staff via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/rHGNCbftykw/
No comments:
Post a Comment